BG Medicine, Inc. (BGMD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 17, 2026, 9:30 AM EST

BG Medicine Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2015FY 2014FY 2013FY 2012FY 2011
Period Ending
Dec '15 Dec '14 Dec '13 Dec '12 Dec '11
Cash & Equivalents
1.534.127.7512.7923.87
Cash & Short-Term Investments
1.534.127.7512.7923.87
Cash Growth
-63.01%-46.81%-39.38%-46.44%884.50%
Receivables
0.180.170.320.40.12
Inventory
0.150.40.460.450.21
Prepaid Expenses
0.090.150.310.560.55
Restricted Cash
---0.390.57
Other Current Assets
0.01----
Total Current Assets
1.954.858.8414.5825.32
Property, Plant & Equipment
0.010.120.190.20.3
Other Intangible Assets
0.080.140.190.370.46
Other Long-Term Assets
0.090.130.130.10.04
Total Assets
2.135.239.3515.2426.11
Accounts Payable
0.560.70.971.110.49
Accrued Expenses
0.350.911.993.553.35
Current Portion of Long-Term Debt
-2.964.353.25-
Current Unearned Revenue
0.280.020.040.411.37
Total Current Liabilities
1.184.587.358.325.2
Long-Term Debt
--2.966.61-
Long-Term Unearned Revenue
0.23----
Other Long-Term Liabilities
0.110.090.110.010.02
Total Liabilities
1.524.6710.4214.935.22
Common Stock
0.010.010.030.020.02
Additional Paid-In Capital
164.32161.55151.84137.38134.19
Retained Earnings
-166.31-161-152.94-137.09-113.32
Total Common Equity
-1.980.56-1.070.3120.89
Shareholders' Equity
0.620.56-1.070.3120.89
Total Liabilities & Equity
2.135.239.3515.2426.11
Total Debt
-2.967.319.86-
Net Cash (Debt)
1.531.160.442.9323.87
Net Cash Growth
31.13%166.13%-85.08%-87.73%-
Net Cash Per Share
0.160.140.060.585.41
Filing Date Shares Outstanding
11.328.636.986.895
Total Common Shares Outstanding
11.328.636.985.134.99
Working Capital
0.770.271.496.2620.11
Book Value Per Share
-0.170.06-0.150.064.19
Tangible Book Value
-2.050.42-1.26-0.0620.44
Tangible Book Value Per Share
-0.180.05-0.18-0.014.09
Machinery
0.480.720.844.534.83
Leasehold Improvements
-0.030.030.460.46
Source: S&P Global Market Intelligence. Standard template. Financial Sources.